266 related articles for article (PubMed ID: 31913282)
1. Clinically accurate diagnosis of Alzheimer's disease via multiplexed sensing of core biomarkers in human plasma.
Kim K; Kim MJ; Kim DW; Kim SY; Park S; Park CB
Nat Commun; 2020 Jan; 11(1):119. PubMed ID: 31913282
[TBL] [Abstract][Full Text] [Related]
2. Plasma Levels of Amyloid-β Peptides and Tau Protein in Mexican Patients with Alzheimer's Disease.
Castillo-Mendieta T; Arana-Lechuga Y; Campos-Peña V; Sosa AL; Orozco-Suarez S; Pinto-Almazán R; Segura-Uribe J; Javier Rodríguez-Sánchez de Tagle A; Ruiz-Sánchez E; Guerra-Araiza C
J Alzheimers Dis; 2021; 82(s1):S271-S281. PubMed ID: 34151786
[TBL] [Abstract][Full Text] [Related]
3. Portable electrochemical micro-workstation platform for simultaneous detection of multiple Alzheimer's disease biomarkers.
Liu Y; Huang Z; Xu Q; Zhang L; Liu Q; Xu T
Mikrochim Acta; 2022 Feb; 189(3):91. PubMed ID: 35129691
[TBL] [Abstract][Full Text] [Related]
4. Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease.
Yang CC; Chiu MJ; Chen TF; Chang HL; Liu BH; Yang SY
J Alzheimers Dis; 2018; 61(4):1323-1332. PubMed ID: 29376870
[TBL] [Abstract][Full Text] [Related]
5. The Levels of Amyloid
Xia C; Ma Q
Comput Math Methods Med; 2021; 2021():7135399. PubMed ID: 34966443
[TBL] [Abstract][Full Text] [Related]
6. Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study.
Brickman AM; Manly JJ; Honig LS; Sanchez D; Reyes-Dumeyer D; Lantigua RA; Lao PJ; Stern Y; Vonsattel JP; Teich AF; Airey DC; Proctor NK; Dage JL; Mayeux R
Alzheimers Dement; 2021 Aug; 17(8):1353-1364. PubMed ID: 33580742
[TBL] [Abstract][Full Text] [Related]
7. Plasma-based diagnostic and screening platform using a combination of biosensing signals in Alzheimer's disease.
Kim HJ; Kim H; Park D; Yoon DS; San Lee J; Hwang KS
Biosens Bioelectron; 2023 Jun; 230():115246. PubMed ID: 37003061
[TBL] [Abstract][Full Text] [Related]
8. Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis.
Koychev I; Jansen K; Dette A; Shi L; Holling H
J Alzheimers Dis; 2021; 79(1):177-195. PubMed ID: 33252080
[TBL] [Abstract][Full Text] [Related]
9. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
[TBL] [Abstract][Full Text] [Related]
10. A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's disease.
Shahpasand-Kroner H; Klafki HW; Bauer C; Schuchhardt J; Hüttenrauch M; Stazi M; Bouter C; Wirths O; Vogelgsang J; Wiltfang J
Alzheimers Res Ther; 2018 Dec; 10(1):121. PubMed ID: 30526652
[TBL] [Abstract][Full Text] [Related]
11. Multiplex immunoassay measurement of amyloid-β
Vogelgsang J; Shahpasand-Kroner H; Vogelgsang R; Streit F; Vukovich R; Wiltfang J
Exp Brain Res; 2018 May; 236(5):1241-1250. PubMed ID: 29480353
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
Bousiges O; Cretin B; Lavaux T; Philippi N; Jung B; Hezard S; Heitz C; Demuynck C; Gabel A; Martin-Hunyadi C; Blanc F
J Alzheimers Dis; 2016; 51(4):1069-83. PubMed ID: 26923009
[TBL] [Abstract][Full Text] [Related]
13. Potential Value of Plasma Amyloid-β, Total Tau, and Neurofilament Light for Identification of Early Alzheimer's Disease.
Shi Y; Lu X; Zhang L; Shu H; Gu L; Wang Z; Gao L; Zhu J; Zhang H; Zhou D; Zhang Z
ACS Chem Neurosci; 2019 Aug; 10(8):3479-3485. PubMed ID: 31145586
[TBL] [Abstract][Full Text] [Related]
14. The CSF p-tau181/Aβ42 Ratio Offers a Good Accuracy "In Vivo" in the Differential Diagnosis of Alzheimer's Dementia.
Santangelo R; Dell'Edera A; Sala A; Cecchetti G; Masserini F; Caso F; Pinto P; Leocani L; Falautano M; Passerini G; Martinelli V; Comi G; Perani D; Magnani G
Curr Alzheimer Res; 2019; 16(7):587-595. PubMed ID: 31345148
[TBL] [Abstract][Full Text] [Related]
15. Brain Amyloid-β Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer's Disease.
Li WW; Shen YY; Tian DY; Bu XL; Zeng F; Liu YH; Chen Y; Yao XQ; Li HY; Chen DW; Zhou FY; Yang H; Li QM; Bao WQ; Guan YH; Zhou HD; Jin RB; Wang YJ
J Alzheimers Dis; 2019; 69(1):169-178. PubMed ID: 30958377
[TBL] [Abstract][Full Text] [Related]
16. Freestanding Nanofiber-Assembled Aptasensor for Precisely and Ultrafast Electrochemical Detection of Alzheimer's Disease Biomarkers.
Liu H; Yuan X; Liu T; Zhang W; Dong H; Chu Z
Adv Healthc Mater; 2024 Jun; 13(15):e2304355. PubMed ID: 38387159
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.
Wang T; Xiao S; Liu Y; Lin Z; Su N; Li X; Li G; Zhang M; Fang Y
Int J Geriatr Psychiatry; 2014 Jul; 29(7):713-9. PubMed ID: 24318929
[TBL] [Abstract][Full Text] [Related]
18. Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.
Chatterjee P; Elmi M; Goozee K; Shah T; Sohrabi HR; Dias CB; Pedrini S; Shen K; Asih PR; Dave P; Taddei K; Vanderstichele H; Zetterberg H; Blennow K; Martins RN
J Alzheimers Dis; 2019; 71(3):775-783. PubMed ID: 31424403
[TBL] [Abstract][Full Text] [Related]
19. Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid.
Jia L; Qiu Q; Zhang H; Chu L; Du Y; Zhang J; Zhou C; Liang F; Shi S; Wang S; Qin W; Wang Q; Li F; Wang Q; Li Y; Shen L; Wei Y; Jia J
Alzheimers Dement; 2019 Aug; 15(8):1071-1080. PubMed ID: 31422798
[TBL] [Abstract][Full Text] [Related]
20. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
